API SUPPLIERS

API Suppliers

31

US DMFs Filed

1

CEP/COS Certifications

0

JDMFs Filed

2

Other Certificates

7

Other Suppliers

26

API REF. PRICE (USD / KG)

95

API Market Place

23

INTERMEDIATES

2

DOSSIERS // FDF

USA (Orange Book)

0

Europe

3

Canada

0

Australia

0

South Africa

0

Uploaded Dossiers

8

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

FDF Market Place

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

1

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Full Screen View

Burke Neurological Institute

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Burke Neurological Institute Receives a $45 Million NIH Grant to Study a Vitamin B1 Precursor for Treatment of Alzheimer’s Disease in Multi-center Cli...

Details:

The follow-up trial will expand on previous work completed at BNI, suggesting that high levels of benfotiamine significantly slowed the rate of functional decline in participants with mild cognitive impairment or early AD.

Lead Product(s): Benfotiamine

Therapeutic Area: Neurology Product Name: Undisclosed

Highest Development Status: Phase IIProduct Type: Small molecule

Partner/Sponsor/Collaborator: National Institutes of Health

Deal Size: $45.0 million Upfront Cash: Undisclosed

Deal Type: Funding July 07, 2022

ASK
US

Upload
your Marketing & Sales content

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Find Drugs in Development News & Deals for Prestwick3_000654

Prestwick3_000654

Prestwick3_000654

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

31 API Suppliers

1 USDMF

2 JDMF

7 EU WC

11 KDMF

26 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

INTERMEDIATES

2 Suppliers

DOSSIERs // Finished Dosage Formulations

11 Dossiers

3 Europe

8 Listed Dossiers

MARKET PLACE

23 APIs

ANALYTICAL SOLUTION(s)

2 Analytical Solutions

DIGITAL CONTENT

1 News

API SUPPLIERS

API REF. PRICE (USD / KG)

INTERMEDIATES

DOSSIERS // FDF

GLOBAL SALES (USD Million)

EXCIPIENTS

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

REF STANDARD

SERVICES

Burke Neurological Institute Receives a $45 Million NIH Grant to Study a Vitamin B1 Precursor for Treatment of Alzheimer’s Disease in Multi-center Cli...

What are you looking for?